2026 Q2 - tulosraportti
65 päivää sitten
‧51 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 651 | ||
| 499 | ||
| 1 | ||
| 1 900 | ||
| 2 989 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 15.4.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 1.9. | ||
2025 Q4 - tulosraportti 15.4. | ||
2025 Q2 - tulosraportti 28.8.2025 | ||
2024 Q4 - tulosraportti 10.4.2025 | ||
2024 Q2 - tulosraportti 29.8.2024 |
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·4 t sitten · MuokattuQuite typical when the share price falls a few percent, then there come heaps of doomsday prophecies 😱 And when the share price goes up a few percent, then …🥂👏👏💵💵🎇🚀
·7 t sittenReplying to the post below me here: Thomas45, I think you are turning cause and effect a bit on its head here! Why did retail investors come in the first place? Was it because Erik and management were good at generating attention, or because the company started delivering results that made it interesting to invest in? I think the latter is clearly the most important explanation! You can market a company until you are blue in the face, but without substance you won't get very far over time. It wasn't interviews and podcasts that caused circVec to deliver steadily better results, that got a Top-5 Pharma to enter into a funded development collaboration, or that gave the company a technology with a potential that increasingly more people started to open their eyes to! That is precisely the point. When you build a good product and deliver results, the interest comes. And with the interest come the investors and the capital! Then a self-reinforcing effect can occur. Technological advances attract investors, increased interest and higher valuation make it possible to raise capital on much better terms, and the capital in turn makes it possible to accelerate development, strengthen the organization, and create further fundamental values. It is not necessarily hype. That is how growth companies can be built! And right here I think Circio has accomplished something quite impressive. From a situation where the company was practically fighting for survival, to a company with several years of funding, steadily stronger preclinical results, and collaborations with international players. That Erik at the same time understands the importance of communication, visibility, and an engaged shareholder base, I see as a strength, not a sign of weakness. Should he rather have kept quiet about the progress and let the company raise capital on worse terms? Of course expectations and share price can run ahead of the fundamentals. And of course considerable risk remains before the technology is clinically and commercially validated. We must be honest about that! But here, validations could come like a bolt from the blue! There is a reason why Mcap is around 3 Billion and not 8-10-12 ... But to reduce this entire development to a deliberate hype campaign to raise money, I think is a pretty gross simplification and a total miss! Retail did not create the circVec results. The results created the interest from retail. And that interest has helped give Circio the capital that now makes it possible to develop the technology further! That is a pretty significant difference!
I have also said that they have done a fantastic job in all the mentioned areas. But as you yourself say, we have now reached a point where we are hanging in thin air since hope has run a bit ahead of the fundamentals and people have wrung everything they can out of the momentum created by preclinical results. The money is in the bank and the company can safely continue its work. The question is how long we will manage to stay in the air? New results seem to be postponed and autumn is over any second now. And I am not negative about the technology. Furthermore, it is of course banal to reduce this to a simple hype campaign because it is the best case of the century. Just a tiny bit pre-sold😅 And thanks @7fjell for a constructive and pleasant reply😊- ·10 t sitten · MuokattuAt the risk of blaspheming a little in church . I reacted a bit to the interview with wicklund and the turnaround from targowax to Circio and the importance of getting the retail investors on board and the importance of keeping interest up by using different channels. What I am left with is that the whole thing was a campaign to drive up the share price and raise the money they needed. Then the question is: What is it we are seeing now when they even raised 200 mill extra? This is going to take a long time. If it succeeds. Wicklund appears satisfied with the turnaround and admits to having used retail to turn the company around. I am not saying this is failing, but it has been consciously hyped by management. Now you can all kill me😅
If you know the history of Targowax, which had a promising development path but was financially halted when the institutional investors did not believe in it, then it is completely correct that retail has been the top priority at Circio. Why? Because you can sell yourself in a completely different way and with a lesser degree of scrutiny of actual results. Then Circio has delivered promising progress so far, enough that the private placement was viable. It did, however, come as a bonus for the company based on results and financial backbone through the retail investors.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
65 päivää sitten
‧51 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·4 t sitten · MuokattuQuite typical when the share price falls a few percent, then there come heaps of doomsday prophecies 😱 And when the share price goes up a few percent, then …🥂👏👏💵💵🎇🚀
- ·7 t sittenReplying to the post below me here: Thomas45, I think you are turning cause and effect a bit on its head here! Why did retail investors come in the first place? Was it because Erik and management were good at generating attention, or because the company started delivering results that made it interesting to invest in? I think the latter is clearly the most important explanation! You can market a company until you are blue in the face, but without substance you won't get very far over time. It wasn't interviews and podcasts that caused circVec to deliver steadily better results, that got a Top-5 Pharma to enter into a funded development collaboration, or that gave the company a technology with a potential that increasingly more people started to open their eyes to! That is precisely the point. When you build a good product and deliver results, the interest comes. And with the interest come the investors and the capital! Then a self-reinforcing effect can occur. Technological advances attract investors, increased interest and higher valuation make it possible to raise capital on much better terms, and the capital in turn makes it possible to accelerate development, strengthen the organization, and create further fundamental values. It is not necessarily hype. That is how growth companies can be built! And right here I think Circio has accomplished something quite impressive. From a situation where the company was practically fighting for survival, to a company with several years of funding, steadily stronger preclinical results, and collaborations with international players. That Erik at the same time understands the importance of communication, visibility, and an engaged shareholder base, I see as a strength, not a sign of weakness. Should he rather have kept quiet about the progress and let the company raise capital on worse terms? Of course expectations and share price can run ahead of the fundamentals. And of course considerable risk remains before the technology is clinically and commercially validated. We must be honest about that! But here, validations could come like a bolt from the blue! There is a reason why Mcap is around 3 Billion and not 8-10-12 ... But to reduce this entire development to a deliberate hype campaign to raise money, I think is a pretty gross simplification and a total miss! Retail did not create the circVec results. The results created the interest from retail. And that interest has helped give Circio the capital that now makes it possible to develop the technology further! That is a pretty significant difference!I have also said that they have done a fantastic job in all the mentioned areas. But as you yourself say, we have now reached a point where we are hanging in thin air since hope has run a bit ahead of the fundamentals and people have wrung everything they can out of the momentum created by preclinical results. The money is in the bank and the company can safely continue its work. The question is how long we will manage to stay in the air? New results seem to be postponed and autumn is over any second now. And I am not negative about the technology. Furthermore, it is of course banal to reduce this to a simple hype campaign because it is the best case of the century. Just a tiny bit pre-sold😅 And thanks @7fjell for a constructive and pleasant reply😊
- ·10 t sitten · MuokattuAt the risk of blaspheming a little in church . I reacted a bit to the interview with wicklund and the turnaround from targowax to Circio and the importance of getting the retail investors on board and the importance of keeping interest up by using different channels. What I am left with is that the whole thing was a campaign to drive up the share price and raise the money they needed. Then the question is: What is it we are seeing now when they even raised 200 mill extra? This is going to take a long time. If it succeeds. Wicklund appears satisfied with the turnaround and admits to having used retail to turn the company around. I am not saying this is failing, but it has been consciously hyped by management. Now you can all kill me😅If you know the history of Targowax, which had a promising development path but was financially halted when the institutional investors did not believe in it, then it is completely correct that retail has been the top priority at Circio. Why? Because you can sell yourself in a completely different way and with a lesser degree of scrutiny of actual results. Then Circio has delivered promising progress so far, enough that the private placement was viable. It did, however, come as a bonus for the company based on results and financial backbone through the retail investors.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 651 | ||
| 499 | ||
| 1 | ||
| 1 900 | ||
| 2 989 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 15.4.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 1.9. | ||
2025 Q4 - tulosraportti 15.4. | ||
2025 Q2 - tulosraportti 28.8.2025 | ||
2024 Q4 - tulosraportti 10.4.2025 | ||
2024 Q2 - tulosraportti 29.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
65 päivää sitten
‧51 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 15.4.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 1.9. | ||
2025 Q4 - tulosraportti 15.4. | ||
2025 Q2 - tulosraportti 28.8.2025 | ||
2024 Q4 - tulosraportti 10.4.2025 | ||
2024 Q2 - tulosraportti 29.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·4 t sitten · MuokattuQuite typical when the share price falls a few percent, then there come heaps of doomsday prophecies 😱 And when the share price goes up a few percent, then …🥂👏👏💵💵🎇🚀
- ·7 t sittenReplying to the post below me here: Thomas45, I think you are turning cause and effect a bit on its head here! Why did retail investors come in the first place? Was it because Erik and management were good at generating attention, or because the company started delivering results that made it interesting to invest in? I think the latter is clearly the most important explanation! You can market a company until you are blue in the face, but without substance you won't get very far over time. It wasn't interviews and podcasts that caused circVec to deliver steadily better results, that got a Top-5 Pharma to enter into a funded development collaboration, or that gave the company a technology with a potential that increasingly more people started to open their eyes to! That is precisely the point. When you build a good product and deliver results, the interest comes. And with the interest come the investors and the capital! Then a self-reinforcing effect can occur. Technological advances attract investors, increased interest and higher valuation make it possible to raise capital on much better terms, and the capital in turn makes it possible to accelerate development, strengthen the organization, and create further fundamental values. It is not necessarily hype. That is how growth companies can be built! And right here I think Circio has accomplished something quite impressive. From a situation where the company was practically fighting for survival, to a company with several years of funding, steadily stronger preclinical results, and collaborations with international players. That Erik at the same time understands the importance of communication, visibility, and an engaged shareholder base, I see as a strength, not a sign of weakness. Should he rather have kept quiet about the progress and let the company raise capital on worse terms? Of course expectations and share price can run ahead of the fundamentals. And of course considerable risk remains before the technology is clinically and commercially validated. We must be honest about that! But here, validations could come like a bolt from the blue! There is a reason why Mcap is around 3 Billion and not 8-10-12 ... But to reduce this entire development to a deliberate hype campaign to raise money, I think is a pretty gross simplification and a total miss! Retail did not create the circVec results. The results created the interest from retail. And that interest has helped give Circio the capital that now makes it possible to develop the technology further! That is a pretty significant difference!I have also said that they have done a fantastic job in all the mentioned areas. But as you yourself say, we have now reached a point where we are hanging in thin air since hope has run a bit ahead of the fundamentals and people have wrung everything they can out of the momentum created by preclinical results. The money is in the bank and the company can safely continue its work. The question is how long we will manage to stay in the air? New results seem to be postponed and autumn is over any second now. And I am not negative about the technology. Furthermore, it is of course banal to reduce this to a simple hype campaign because it is the best case of the century. Just a tiny bit pre-sold😅 And thanks @7fjell for a constructive and pleasant reply😊
- ·10 t sitten · MuokattuAt the risk of blaspheming a little in church . I reacted a bit to the interview with wicklund and the turnaround from targowax to Circio and the importance of getting the retail investors on board and the importance of keeping interest up by using different channels. What I am left with is that the whole thing was a campaign to drive up the share price and raise the money they needed. Then the question is: What is it we are seeing now when they even raised 200 mill extra? This is going to take a long time. If it succeeds. Wicklund appears satisfied with the turnaround and admits to having used retail to turn the company around. I am not saying this is failing, but it has been consciously hyped by management. Now you can all kill me😅If you know the history of Targowax, which had a promising development path but was financially halted when the institutional investors did not believe in it, then it is completely correct that retail has been the top priority at Circio. Why? Because you can sell yourself in a completely different way and with a lesser degree of scrutiny of actual results. Then Circio has delivered promising progress so far, enough that the private placement was viable. It did, however, come as a bonus for the company based on results and financial backbone through the retail investors.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 651 | ||
| 499 | ||
| 1 | ||
| 1 900 | ||
| 2 989 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt